Using the TipRanks Stock Screener Tool, we identified three companies with high price-to-earnings (P/E) ratios, Strong Buy consensus ratings, and more than 25% upside potential over the next 12 months, making them attractive opportunities for growth-focused investors.
Claim 55% Off TipRanks
New trading tool for APP bulls
Let’s dive into the details.
Why High P/E Stocks
An investment’s real value lies in its expected future growth. High P/E ratios might signal overpricing at first glance, but they often reflect strong optimism for rapid earnings expansion. The key is benchmarking current prices against projected growth paths. Investing in high P/E stocks is essentially wagering on companies with solid fundamentals, ongoing innovation, and expanding markets.
AppLovin (APP)
- P/E Ratio: 68.5x
- Average AppLovin Price Target: $641.81 (32.27% upside)
AppLovin provides AI-powered tools that help businesses grow their advertising reach. AppLovin stock trades at a relatively high valuation, reflecting strong investor expectations for future growth. Much of this premium is tied to its AI-driven ad platform and rapid revenue expansion.
The company is set to report its Q1 2026 earnings on May 6. Yesterday, analysts at Piper Sandler, Bank of America, and Citigroup each reiterated their Buy ratings on APP stock, signaling bullish sentiment going into earnings. However, the high valuation also means the stock is more sensitive to earnings results, as any slowdown in growth could put pressure on shares.
Okta (OKTA)
- P/E Ratio: 63.2x
- Average Okta Price Target: $100.13 (27.20% upside)
Okta provides identity and access management solutions, helping businesses securely manage user logins and data access. OKTA stock trades at a relatively high valuation, driven by strong demand for cybersecurity. Yesterday, Barclays’ four-star-rated analyst Saket Kalia raised his price target on OKTA stock from $85 to $90 while keeping his Buy rating.
CVS Health (CVS)
- P/E Ratio: 56.9x
- Average CVS Stock Price Target: $96.27 (25% upside)
CVS Health is a diversified healthcare company that operates retail pharmacies, health insurance through Aetna, and pharmacy benefit management services. It focuses on providing integrated care, combining pharmacy, insurance, and clinical services under one platform. CVS will report its Q1 2026 earnings on May 6. Heading into earnings, analysts are strongly bullish on CVS stock.